Equites Radar

PHG · Koninklijke Philips N.V. NY Reg

Medical DevicesNetherlandsAnalyst view: none

$26.89

-0.11% last session

End-of-day data · close of 2026-10-23

Mildly bullish3 bullish · 2 bearish technical signals
To mean target: +19.1%

Market cap

$26B

Enterprise value

$32B

Trailing P/E

20.1

Forward P/E

14.2

Dividend yield

4.0%

Beta

0.92

Avg volume

1M

Employees

64K

Daily Change %

-0.11%

5 Days Change

4.58%

10 Days Change

8.16%

30 Days Change

10.10%

60 Days Change

-2.18%

Month to Day Change

13.06%

Year to Day Change

3.28%

Analyst Outlook

Consensus rating—
Recommendation mean (1–5)—
Covering analysts5
Mean price target$32.02
Low price target$26.20
Upside to mean target+19.1%

Analyst estimates change daily — follow the shifts on the Estimate Trends page.

Technical Analysis

RSI (14)71.4
50-day MA$25.57
200-day MA$26.82
Price vs 50-day MA+5.2%
Price vs 200-day MA+0.3%
MACD histogram0.32
Volume vs 3-month avg1.3×
52w low $23.8152w high $31.68

Analyst sentiment over time — PHG

Rec Mean (blue, left — higher = more bullish) vs. price targets (right).

Investment Bank Ratings as of 2026-08-03

Latest call per bank · past 12 months

UBS

Neutral

$0.00

-100.0% vs price
Downgrade · 2026-08-03

Recent rating actions

DateFirmActionRatingPrice target
2026-08-03UBSDowngradeBuy → Neutral$0.00

Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.

Signal Summary as of 2026-10-23

  • bearish: RSI (14): RSI is 71 — overbought territory; the recent run-up may be due for a pause.
  • bullish: Price vs 50-day MA: Trading 5.2% above the 50-day MA ($25.57).
  • bullish: Price vs 200-day MA: Trading 0.3% above the 200-day MA ($26.82).
  • bearish: MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
  • bullish: MACD (12,26,9): MACD histogram is positive (+0.32) — short-term momentum is improving.
  • neutral: 52-week range: Price sits between the 52-week low ($23.81) and high ($31.68).

PHG Price Chart

Loading chart for PHG…

Fundamentals

Revenue (TTM)$18B
EBITDA$2.0B
Free cash flow$2.0B
Operating cash flow$2.0B
Book value / share$13.16
Net Debt / EBITDA2.4
WACC10.0%
Revenue growth0.00%
Earnings growth61.00%

About Koninklijke Philips N.V. NY Reg

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. Koninklijke Philips N.V. has strategic alliance with WellSpan Health to advanced imaging and diagnostics technology products and platforms. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

More in Medical Devices

Screen PHG against the full market on the Radar →

Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.